Joint (JYNT) Trading Down 8.1%

Shares of Joint Corp (NASDAQ:JYNT) fell 8.1% during trading on Thursday . The company traded as low as $15.50 and last traded at $16.04. 872,737 shares were traded during trading, an increase of 585% from the average session volume of 127,339 shares. The stock had previously closed at $17.46.

A number of research firms have commented on JYNT. DA Davidson set a $21.00 target price on shares of Joint and gave the stock a “buy” rating in a report on Thursday. Zacks Investment Research raised shares of Joint from a “hold” rating to a “strong-buy” rating and set a $22.00 price target on the stock in a research report on Tuesday, May 14th. ValuEngine raised shares of Joint from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, February 20th. Lake Street Capital lifted their price target on shares of Joint to $20.00 and gave the stock a “buy” rating in a research report on Friday, March 8th. Finally, Maxim Group reissued a “buy” rating and set a $18.00 price target (up from $11.00) on shares of Joint in a research report on Friday, March 8th. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $18.60.

The stock has a market capitalization of $240.26 million, a price-to-earnings ratio of 401.00, a price-to-earnings-growth ratio of 7.76 and a beta of 0.86. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 4.38.

Joint (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.06. The company had revenue of $10.68 million for the quarter, compared to analysts’ expectations of $8.90 million. Joint had a net margin of 4.50% and a return on equity of 109.02%. On average, equities analysts anticipate that Joint Corp will post 0.22 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Goldman Sachs Group Inc. lifted its position in Joint by 215.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 154,327 shares of the company’s stock valued at $2,431,000 after acquiring an additional 105,385 shares in the last quarter. Nantahala Capital Management LLC lifted its position in Joint by 10.1% in the 4th quarter. Nantahala Capital Management LLC now owns 1,128,693 shares of the company’s stock valued at $9,391,000 after acquiring an additional 103,972 shares in the last quarter. Granite Investment Partners LLC lifted its position in Joint by 87.7% in the 1st quarter. Granite Investment Partners LLC now owns 149,203 shares of the company’s stock valued at $2,350,000 after acquiring an additional 69,711 shares in the last quarter. BlackRock Inc. lifted its position in Joint by 84.8% in the 1st quarter. BlackRock Inc. now owns 58,111 shares of the company’s stock valued at $915,000 after acquiring an additional 26,668 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its position in Joint by 13.9% in the 1st quarter. Acadian Asset Management LLC now owns 217,266 shares of the company’s stock valued at $3,422,000 after acquiring an additional 26,564 shares in the last quarter. 47.76% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Joint (JYNT) Trading Down 8.1%” was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.thelincolnianonline.com/2019/05/23/joint-jynt-trading-down-8-1.html.

About Joint (NASDAQ:JYNT)

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.

See Also: Roth IRA

Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.